Please ensure Javascript is enabled for purposes of website accessibility

Thursday's Top News Headlines

By Motley Fool Staff – Mar 27, 2014 at 4:02AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Here are today's top news stories from

Here are today's top news headlines from Check back throughout the day as this list is updated, and follow us on Twitter at TMFBreaking.

Stock Market Today: Why lululemon and Accenture are on the Move

Morning Movers in Biotech: Clovis Oncology,, Exact Sciences Corporation, GlaxoSmithKline PLC, and Mylan, Inc.

With $9.5 Billion Settlement, Bank of America Clears the Last Major Legal Hurdle

lululemon athletica Beats Q4 Earnings Estimates; Current-Quarter Guidance Below Estimates

Accenture PLC Operating Income Climbs to $951 Million in the Second Quarter

GlaxoSmithKline Recalling Alli After Other Pills Found in Bottles

The Fed Takes Citigroup Down, Lifts Bank of America

Ally Financial Files for IPO That Could Raise More Than $3 Billion

The Boeing Company and Airbus Group Receive Orders Worth $16.6 Billion From ANA Airlines

Initial Jobless Claims Drop 3.1% to 4-Month Low

Will Baxter International Inc's Split Unlock Shareholder Value?

Obama Hops on LNG Train, but Is That Train Even Leaving?

Why BlackBerry Ltd. Shares Slumped This Morning

GameStop Corp Plunges 7% on Soft Holiday Sales, Despite Healthy Guidance

Russia to Set Up Own Payment System

Pending Home Sales Drop 0.8%

Q4 GDP Growth Revised Up to 2.6%

Office Is Coming to the iPad, but Microsoft's Stock Is Stuck in Neutral

NRG Energy, Inc. Buys Rooftop Solar Company

Q4 2013 Corporate Profit Up 2%

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.